Related Experiment Video
Updated: Feb 15, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Correlation of Gli1 and HER2 expression in gastric cancer: Identification of novel target
Xinyu Shao1, Xiaoyi Kuai1, Zhi Pang1
1The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215006, P.R. China.
Abstract:
HER2 becomes the standard of care for guiding adjuvant treatment of gastric cancer with trastuzumab in recent years. However, the usage of this target agent is still limited because of the resistance to trastuzumab or the negative expression of HER2 in tumor tissues. The Gli1 and HER2 both play an important role in the pathogenesis of gastric cancer. However, the correlation of them is still unclear. Here we found Gli1 and HER2 are highly expressed in gastric cancer tissues, and they are positively related. Next, we found Gli1 positive patients live a shorter survival time no matter HER2 positive or negative. Furthermore, univariate and multivariate analysis revealed that venous invasion, HER2 expression, Gli1 expression were independent prognostic factors for the survival time in gastric cancer. In addition, suppressing the expression level of Gli1 can decrease the cell viability and migration ability in cells and subcutaneous tumors. Finally, we found that HER2 may regulate Gli1 by Akt-mTOR-p70S6K pathway. Inhibit of HER2 and SMO have synergistic effect on reduction of cell viability. In conclusion, Gli1 is a favorable prognostic indicator in gastric cancer. As a novel target, Gli1 worth further study, especially in Her2-targeted therapy-resistant cancers.
Insights
Gli1 is highly expressed in gastric cancer and linked to shorter survival. Targeting Gli1 may improve outcomes, especially in patients resistant to HER2-targeted therapies like trastuzumab.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- HER2 is a standard treatment for gastric cancer, but resistance and negative expression limit its use.
- Both Gli1 and HER2 are implicated in gastric cancer pathogenesis, but their relationship is not well understood.
Purpose of the Study:
- To investigate the correlation between Gli1 and HER2 expression in gastric cancer.
- To evaluate Gli1 as a prognostic factor and potential therapeutic target in gastric cancer.
Main Methods:
- Analysis of Gli1 and HER2 expression in gastric cancer tissues.
- Correlation studies and survival analysis (univariate and multivariate).
- In vitro and in vivo experiments to assess the effect of Gli1 suppression and combined HER2/SMO inhibition.
Main Results:
- Gli1 and HER2 are highly expressed and positively correlated in gastric cancer.
- Gli1 expression is associated with shorter survival, regardless of HER2 status.
- Gli1 and HER2 expression, along with venous invasion, are independent prognostic factors.
- Gli1 suppression reduces cancer cell viability and migration.
- HER2 may regulate Gli1 via the Akt-mTOR-p70S6K pathway; combined HER2 and SMO inhibition shows synergistic effects.
Conclusions:
- Gli1 is a significant prognostic indicator in gastric cancer.
- Gli1 represents a potential therapeutic target, particularly for HER2-targeted therapy-resistant gastric cancers.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Targeted Cancer Therapies
There are several types of targeted therapies against...
Correlations
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Correlation
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...

